Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers



Rating:

Share or cite this content

Citations should be made in the following way:
G.E. Carpagnano, D. Lacedonia, E. Costantino, A.R. Depalo, C. Ruggeri, G.P. Palladino, M.P. Foschino Barbaro (Foggia, Italy). Exhaled MMP-9 in lung cancer. Eur Respir J 2012; 40: Suppl. 56, 310

Member's Comments

No comment yet.

Related content which might interest you: Dermcidin identification from exhaled air for lung cancer diagnosis Source: Eur Respir J 2010; 35: 1182-1185 Year: 2010 Exhaled aldehydes as markers of disease in lung cancer patients Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients? Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002 Tumor size and inflammatory cytokines in exhaled breath condensate in patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Cytokine pattern in the exhaled breath of patients with planocellular lung carcinomas Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 HPV in exhaled breath condensate of lung cancer patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Neutrophilic airways inflammation in lung cancer: The role of exhaled LTB-4 and IL-8 Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 The impact of lung cancer subtypes, smoking status and corticosteroid treatment on exhaled nitric oxide levels in patients with lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Increased levels of fractional exhaled nitric oxide after chemotherapy for lung cancer. Ongoing study Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Exhaled nitric oxide (eNO) and lung transplantation (LTx): impact of the native lung? Source: Eur Respir J 2001; 18: Suppl. 33, 179s Year: 2001 Vascular endothelial growth factor (VEGF) in serum and exhaled breath condensate (EBC) of subjects with non-small cell lung cancer (NSCLC) Source: Eur Respir J 2007; 30: Suppl. 51, 205s Year: 2007 Exhaled nitric oxide after lung transplantation: impact of the native lung Source: Eur Respir J 2003; 21: 429-432 Year: 2003 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004